missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD43/Sialophorin Antibody (SPN/1094), Alexa Fluor™ 594, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-47880AF594
This item is not returnable.
View return policy
Description
CD43/Sialophorin Monoclonal specifically detects CD43/Sialophorin in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunofluorescence.
Specifications
| CD43/Sialophorin | |
| Monoclonal | |
| Alexa Fluor 594 | |
| 50 mM sodium borate with 0.05% sodium azide | |
| SPN | |
| Recombinant full-length human CD43/Sialophorin protein (Uniprot: P16150) | |
| Primary | |
| It recognizes a cell surface glycoprotein of 95/115/135kDa (depending upon the extent of glycosylation), identified as CD43. 70-90% of T-cell lymphomas and from 22-37% of B-cell lymphomas express CD43. No reactivity has been observed with reactive B-cells. So a B-lineage population that co-expresses CD43 is highly likely to be a malignant lymphoma, especially a low-grade lymphoma, rather than a reactive B-cell population. When CD43 antibody is used in combination with anti-CD20, effective immunophenotyping of the lymphomas in formalin-fixed tissues can be obtained. Co-staining of a lymphoid infiltrate with anti-CD20 and anti-CD43 argues against a reactive process and favors a diagnosis of lymphoma. | |
| Store at 4°C in the dark. |
| Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunofluorescence | |
| SPN/1094 | |
| Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunofluorescence | |
| CD43 antigen, CD43), Galactoglycoprotein, GALGP, Leukocyte sialoglycoprotein, Sialophorin, sialophorin (gpL115, leukosialin, CD43) | |
| Mouse | |
| 0.1 mL | |
| 6693 | |
| Human | |
| IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction